PathAI company overview
About
Expert Vetted Data
Public disclosures rarely capture a company's internal dynamics or the true state of its technology. Gain first-hand insight by speaking with former PathAI executives.
Ownership & Key Financials
Revenue
Investors
Revenue / FTE
Ownership
FTEs
Products & Services
Clinical trial services
Description: AI-enabled clinical development services supporting clinical trials, endpoint development, and companion diagnostics.Name: Clinical Devel•••••• ••••••••, ••••••••• ••••••••••• •••••••••••, ••••••• •••••••• ••••••••• ••••: •••• •• •••••••••••••• ••••••••• ••• •••• ••• •••••••• •••••••• ••••••, •••••••••• ••••••••• •••••••••••, ••• •••••••••• •••••••••• •••••••••• •••••••••.••• ••••••••: •••/•••• ••••••••••, ••••••••••• ••••••••• •••••, ••••• •••••••• •••••••••••, ••••••• •••••••••• •••••••, •••••••••• ••••••••
Lab diagnostics
Description: AI-assisted laboratory diagnostic solutions and digital pathology platforms for clinical diagnostic workflows.Name: AISight Image Managem••• ••••••, ••••••• •• ••••••• ••••••••• ••••••••••• ••••: •••• •• •••••••••• •••• ••• ••••••••• •••••••••••• ••• ••••••• •••••••••, •••••••• ••••••••••, ••• ••••••• ••••••• •• •••••••• ••••••••.••• ••••••••: ••• •••(•) •••••••••, ••••• ••••• •••••••, ••••••••• ••••••• •••••••, •••• ••••••••••••••, ••••• ••••••• ••• •••••••••
AI pathology algorithms
Description: AI models for histopathology data analysis providing segmentation, morphological features, and patient-level predictions including drug r•••••••, ••••••••, ••• •••••••• •••••••.••••: ••••••••••••••, •••-••-••, •••-••, ••••••••••, ••••••••••, •••••••••••, •••-••••, •••-••••, •••••••••••••• ••••: •••• •• ••••••••••••••••• ••••••••• ••• •••••••• •••••••••• ••• ••••••••• •••••• ••••••, ••••••••• ••••••••••••••, ••• •••••••••• •••• ••••••••• ••• ••••••••••• •••••••••.••• ••••••••: ••••••••• •••••• ••••••••, ••••••••• ••••••••••••••, ••••••• ••••••••••••••••, ••••••-•••• •••••••••• ••••••••, ••••••••••••• ••••••• ••••••••••
Pricing & Go-to-market
Typical Contract Length
• •••••• •• • ••••• •••• •••••••• •• ••••••••••, •••• •••••• •••••••••••••• ••••••••• ••••••••• •••••• •••••• •••••••••
Pricing model
License fee model rather than SaaS, with pricing based on customer budget and appetite, offering white-glove service. Multi-tiered platform licensing •••••••••••••• ••••••• •••••••• ••• •••• (•••) ••• •••••••••• (••) •••••••••, •••• •••••• ••••••••••• •••• •• ••••••••••••• $•••-••• •••• ••••••••• ••••• •••• •••••• •••-••••• •• •••-••••••••
Average Sales Value
$• ••••••• •• $•• •••••••
Average Sales Cycle
••••••••••••• • ••••, ••••••••• ••• •• •••• ••••••••-•••••• ••••••••• •• ••• •••••• •••••••••
Growth Review
| Company Name | Revenue | FTE | Proprietary Insights | HQ | Ownership Type |
|---|---|---|---|---|---|
 PathAI | - | ••• '•• | - | USA | P•••••••• |
 Akoya Biosciences, Inc. | - | - | - | - | - |
| Akoya Biosciences, Inc. | - | - | - | - | - |
 NanoString Technologies, Inc. | - | - | - | - | F•••••••••••• |
| NanoString Technologies, Inc. | - | - | - | - | F•••••••••••• |
 Tempus AI | - | - | - | - | P••••• |
| Tempus AI | - | - | - | - | P••••• |
 Ibex Medical Analytics | - | - | - | - | V•••••••• |
| Ibex Medical Analytics | - | - | - | - | V•••••••• |
 Visiopharm | - | - | - | - | V•••••••• |
| Visiopharm | - | - | - | - | V•••••••• |
Experts highlight PathAI's operational execution and market approach, while noting market evolution and timing considerations as a potential constraint.
What does Origin provide on PathAI?
Origin provides a structured company snapshot of PathAI, combining expert-led insights with analysis across business model, customers, competitors, and market dynamics. The profile is designed to support research, competitive analysis, and commercial due diligence workflows.
How is Origin's analysis of PathAI different from traditional company databases?
Traditional company databases often focus on surface-level metadata such as ownership, funding, and company descriptions. Origin complements these sources with qualitative insights informed by expert interviews, helping teams understand how PathAI operates, competes, and creates value in practice.
Is Origin suitable for researching private companies like PathAI?
Yes. Origin is built to support research on private companies, where public information can be limited or inconsistent. It focuses on insight depth and operational context, which can be useful when evaluating companies like PathAI for investment, partnership, or competitive analysis.
Where does Origin's information on PathAI come from?
Origin insights are derived from expert interviews conducted by Dialectica, combined with structured analysis and secondary validation where appropriate. This approach prioritises first-hand operational perspectives alongside supporting evidence, rather than relying solely on aggregated public data.
Can Origin support commercial due diligence on PathAI?
Origin can support early-stage commercial due diligence by helping teams quickly understand positioning, value drivers, customer dynamics, and potential risks related to PathAI. It is typically used to shape hypotheses and focus areas before deeper primary research.
How does Origin compare to Crunchbase or PitchBook for analysing PathAI?
Crunchbase and PitchBook primarily focus on company metadata, ownership, funding history, and transactions. Origin complements those sources by adding qualitative, insight-led analysis focused on business fundamentals, go-to-market execution, customer reality, and competitive positioning for companies like PathAI.
How can Origin support portfolio monitoring or add-on analysis for companies like PathAI?
For PE-backed contexts, Origin can support monitoring by surfacing changes in competitive intensity, customer demand signals, and go-to-market effectiveness. It can also inform add-on analysis by clarifying adjacency opportunities and how a target like PathAI may fit within a broader platform strategy.
What does Origin typically reveal about pricing and go-to-market strategy for enterprise software companies like PathAI?
For enterprise software, Origin often focuses on pricing logic, contract structure, buyer personas, procurement friction, and channel strategy. For companies like PathAI, this can help teams assess how revenue is created, what drives expansion, and where sales cycles or retention may impact outcomes.
Relevant Companies
Castor
Modular software platform for clinical research organizations and trial sponsors to manage study design, patient recruitment, data collection, and trial monitoring activities for clinical trials.
HQ
Ownership
Investors
ClinicMind
Practice management platform for healthcare providers to manage patient acquisition, scheduling, electronic health records, billing, revenue cycle management, and patient retention across the full care cycle.